The Role of Packaging Design In Drug Development – Pubrica

1. THE ROLE OF PACKAGING DESIGNIN DRUGDEVELOPMENT An Academic presentationby Dr.NancyAgnes,Head,TechnicalOperations,Pubrica Group: www.pubrica.com Email:sales@pubrica.com

2. Today'sDiscussion Outline Introduction Packaging Is Key to Maintaining Drug Stability Packaging Considerations forGenerics New Healthcare Markets Bring New Challenges Conclusion

3. Introduction Packaging is a significant segment in developing different drugs, as it can incredibly influence drug security andwellbeing. Packaging materialis picked based on its viability and different attributes that empower it to save the quality, power, and health of the drugitems. Contd...

4. As the business advances, the packaging is getting more significant both to the fruitful promoting of items and to the health and security ofpatients. As an outcome, there are more reasons than any time in recent memory to incorporate bundling contemplations from the get-go in the medication developmentmeasure.

5. Stability testing of drug items and similarity testing of packaging materials are fundamental pieces of R&D in the drugbusiness. Packaging IsKey to Maintaining DrugStability The security of medication in solid and fluid measurement structures relies upon the adequacy of the bundling materials to shield the medication from compound debasement and changes in essential qualities like appearance, hardness, friability, disintegration, deterioration, weight variety, dampness content, and mechanicaltoughness. This is exceptionally fundamental for the capacity of items under speed-upconditions.

7. Packaging Considerations forGenerics Generic companies frequently follow the innovator or reference bundling for theiritem. However, the nonexclusive medication item plan group needs to consider the significance of bundling at a previous phase ofimprovement. Contd...

8. Albeit the name of the medication item is something similar, there might be numerous distinctions in the item, forexample, Source of the API, andexcipient. Quantitative extents of active drugingredients. Drug producing process and parameters because of the presence of licenses andexclusivity.

9. NewHealthcare Markets Bring NewChallenges Packaging in the healthcare industry faces various obstacles, including ever-increasing regulatory requirements in a number ofcountries. Packaging changes are being driven by complex molecules/formulas and biologics, which interfere with traditional packagingmaterials. Contd...

10. With the growing demand for new packaging materials and the need to maintain product-package compatibility during the R&D stage to ensure the materials' protection, the task of the packaging technologist should not be overlooked during the product development process. Industry developments are driving the use of cost-effective, creative packaging solutionstoday. This is also another reason why it is important to consider packaging during the early stages of drug production to prevent any surprises duringcommercialization. Contd...

11. To be effective, changes in hospital administration toward more self-administration processes necessitate consistent medical communicationof product usages, packaging system simplification, and highly compliantpackaging. Although packaging is crucial for the marketing of any pharmaceutical product, pharmaceutical packaging is heavilyregulated. As a result, it is critical for pharma R&D packaging professionals to strike a balance between meeting safety, efficiency, and regulatory requirements while minimising costs during the early stages ofproduction.

12. Conclusion In recent years, there has been a larger focus on protecting drug transportation (cold chain, drop checks, etc.) and maintaining drug purity (track and trace, serialisation), both of which include packagingR&D.

13. ContactUs UNITEDKINGDOM +44-7424810299 INDIA +91-9884350006 EMAIL sales@pubrica.com